"Light-sheet microscopy has already allowed us to see things we couldn't dream of before, such as imaging the entire embryonic development of the fruit fly with subcellular resolution," says Lars Hufnagel, who develops the technology at EMBL and uses it in his research on tissue development. "In a company setting the technology can be pushed even further, and made available to many more people than we could have catered to as research groups" says Jan Ellenberg, who teamed up with Lars to develop light sheet technology for studying early mammalian development.

Luxendo will initially be hosted on the EMBL campus, and will focus exclusively on developing and commercializing light-sheet microscopy for biomedical research.

"Being incubated at EMBL is a win-win situation," says Luxendo CEO Christoph Antz. "It means scientists have access to these new technologies as we develop them, and at the same time we can test and improve the microscopes with our intended users right from the onset."

Although based in Europe, Luxendo aims to serve the research community worldwide.

"EMBL's strong patent portfolio in the field of light-sheet microscopy has been built up over many years and puts Luxendo on a solid footing for competitive development in this field" says Gábor Lamm, Managing Director for EMBLEM.

The company's MuVi-SPIM microscopes -- initially developed by Hufnagel at EMBL -- are already available on the market, with other devices to follow soon.

Videos obtained with MuVi-SPIM microscopes are available here: -- https://youtu.be/cI9AP5BSGzs -- https://youtu.be/MefTPoeVQ3w

Story Source:

The above post is reprinted from materials provided by European Molecular Biology Laboratory (EMBL). Note: Materials may be edited for content and length.